Strides Pharma Science Limited has informed the Exchange about Schedule of meet
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science Limited has scheduled an earnings call with analysts and investors on Tuesday, July 29, 2025, at 4:30 PM IST to discuss its unaudited financial results for the quarter ended June 30, 2025 (Q1FY26). Senior management participants will include Founder & Managing Director Arun Kumar, Group CEO Vikesh Kumar, and Group CFO Badree Komandur. The company has provided international dial-in numbers for participants from India, USA, Singapore, UK, and Hong Kong, and details are also available on the company's website at www.strides.com. The filing was made on July 23, 2025, by Company Secretary Manjula Ramamurthy.
This is a routine advance notice of an upcoming earnings call, so there is no direct impact on the stock price. Investors should watch for the Q1FY26 results on July 29, 2025, for actual performance numbers and management commentary that could influence sentiment.